Facebook
Twitter
LinkedIn
Forward
The gut microbiome is recognized as an important factor in obesity. This webinar will review the interconnection between obesity and the gut microbiome.
|
In this webinar, Dr. Puhl will provide an overview of the nature of weight stigma affecting youth and adults with obesity.
|
Dr. Weber will present and discuss case examples that will increase familiarity with antiobesity medication indications, contraindications, side effect profiles, and medication interactions.
|
This session will review obesity as a chronic low-grade inflammatory state predisposing to chronic diseases including CAD/CVD and COVID-19 complications.
|
|
Many clinicians are concerned with the amount of fat and lack of carbs in low-carb diets and fear they will raise LDL cholesterol and cardiovascular risk.
|
In this webinar, Dr Carl Lavie will discuss the adverse effects that obesity has on the major CVD risk factors and to increase almost all CVD.
|
Nutrition is one of the pillars of obesity treatment. While clinicians are easily able to advise patients what NOT to eat, telling patients what to eat can be harder.
|
As the choices available for anti-obesity pharmacotherapy increase, clinicians are faced with options for addressing key clinical scenarios.
|
This webinar will discuss the latest advances in the management of the pre/post Bariatric patient After attending this webinar, the participants will be able to describe the latest recommendations
|